preview

A Study On Meeting Receptor

Good Essays

MET RECEPTOR Met is a tyrosine kinase receptor, which binds to HGF (Hepatocyte Growth Factor), causing effects through several pathways (including anti-apoptotic mechanisms and cytoskeletal changes), being one of the most important processes during embryogenesis, organ regeneration and tumour invasion (TRUSOLINO; BERTOTTI; COMOGLIO, 2010). MET GENE AND STRUCTURE The c-Met gene is present on chromosome 7q21-31, has 21 exons and 20 introns, with a total length of 120kb. The transcription of this proto-oncogene produces a polypeptide, which after glycosylation, is cleaved in a 50 kD α chain and a 140kD β chain (CIPRIANI, 2009). The mature c-Met receptor is a heterodimer, with a complete extracellular α subunit and a large β subunit, presenting the following extracellular domains: sema (semaphoring domain), PSI (also called MET-Related Sequence - MRS), four IPT domains (immunoglobulin – plexin - transcription domains), and 3 intracellular regions: juxtamembrane (containing tyrosine 1003, which negatively regulates c-MET by inducing its ubiquitination), a tyrosine kinase domain (with tyrosines Y1234 and Y1235, which positively modulate the receptor function) and a carboxy-terminal tail region (containing tyrosines Y1356 and Y1349, responsible for the recruitment of adaptors during the activation of c-MET) (CECCHI; RABE; BOTTARO, 2012; ORGAN; TSAO, 2011). HEPATOCYTE GROWTH FACTOR Hepatocyte Growth Factor (HGF), the main ligand of the c-Met receptor, is a secretory product,

Get Access